Animal Model Market Size & Share 2023 to 2032
Market Size by Animal Type (Mice, Rats, Fish, Birds), Technology (CRISPR, Microinjection), Application (Research & Development), Use (Human, Veterinary), End Use, (Companies, Contract Research Organizations).
Report ID: GMI4435
|
Published Date: June 2023
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Gauri Wani
Animal Model Market Size
Animal Model Market size was valued at USD 19.4 billion in 2022 and is estimated to progress at significant growth rate of 6.9% over the analysis timeframe. High growth of the market can be attributed to several factors such as rising adoption of animal models for biomedical research, surging expenditure & high investments in dug development & discover, growing focus on precision medicine, and extensive applications of animal models in healthcare industry.
Animal Model Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
As per the U.S. government statistics, in 2021, the number of laboratory animals employed in biomedical research were around more than 797,546, with a 2.2% surge as compared to 2019 and 2020. These statistics exclude the number of mice, rats, and fish models that are being used, which further adds up the number of animal models used for research.
Animal model can be defined as a non-human, living, genetically engineered animal that is used for scientific research purpose and investigation of human diseases. Also, these animal models are used for the purpose of better understanding of the human disease process without harming an actual human.
COVID-19 Impact
The emergence of COVID-19 was an unprecedented public health concern that has positively impacted the animal model market. Healthcare sector was also largely affected by the increasing prevalence of COVID-19 cases. However, heavy investments in research activities related to COVID-19 and the increased funding towards R&D activities to innovate novel therapeutics have promoted the use of animal models despite the pandemic.
Several pharmaceutical, biotechnology companies, and clinical research organizations revised their R&D spending to increase clinical trials to focus on the pandemic. Numerous animal models have been studied and employed to study COVID-19 infection. Mice were profoundly employed in infectious disease studies, especially SARS-CoV-2 strain adapted mice after deliberate passaging of virus in lung tissues. Due to such aforementioned factor, a positive impact was observed during the COVID-19 pandemic.
Animal Model Market Trends
The increasing number of pharmaceutical research and development activities is anticipated to drive the market progress. Need for novel drugs to help meet the unmet medical requirements are amongst the key value drivers of research-based pharmaceutical & biotechnology companies. The pharmaceutical sector develops several novel drugs that offer valuable clinical benefits. The surging number of investments by government as well as private players are amongst the prime variables driving the number of pharmaceutical research and development activities.
For instance, according to the Congressional Budget Office, in 2019, the pharmaceutical sector spent USD 83 billion in R&D activities. These expenditures comprises a comprehensive spectrum of activities, such as discovering & testing novel medications and testing for safety-parameters or regulatory purposes.
Animal Model Market Restraint
Stringent regulatory guidelines for animal model usage are put in place to ensure the ethical and responsible use of animals in scientific research. A framework of stringent regulatory and strict guidelines exists to ensure animal welfare. These regulations are exhaustive and vary from country to country. Regulatory guidelines typically require researchers to demonstrate the scientific necessity and potential benefits of using animal models. Research proposals involving animal experimentation are subject to ethical review by institutional animal care and use committees (IACUCs) or similar regulatory bodies. These committees assess the justification, design, and welfare considerations of the proposed studies. Such stringent & variable regulations may hamper the use of animal models in biomedical research, thereby hindering the business expansion.
Animal Model Market Analysis
By animal type, the animal model market is classified into mice, rats, fish, birds, cattle’s, pigs, amphibians, guinea pigs, dogs, cats, rabbits, monkey’s, sheep, hamsters, and other animal types. The mice segment dominated the market in 2022 with approximately 49.2% business share. Mice model is amongst the most common animal model used in studying human disease and human health. High phylogenetic similarities and physiological relatedness to humans, low maintenance, ease of breeding them in the laboratory, and easy availability of a number of inbred strains make mice models most predominantly used for research of human biology and disease.
Further, mice have a relatively short reproductive cycle and lifespan. This characteristic enables researchers to study multiple generations of mice in a relatively short period. Thus, several advantages offered by mice animal model is set to drive the segment trends.
Based on technology, the animal model market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer and other technologies. The CRISPR technology segment is anticipated to witness high growth at a CAGR of 7.3% during the forecast timeframe. The CRISPR technology has accelerated the development of transgenic animals, demonstrating an unprecedented efficiency and easy replicability, thereby limiting the time and expenses for genome editing. This technology has further enabled the production of animal models with more comprehensive genetic modifications as compared to conventional gene-targeting methods. Genome editing approach based on CRISPR system enables the accurate introduction of mutations at target DNA sequences. This technology has fuelled the generation of animal models and significantly contributed to their increased adoption for research purposes.
Based on application, the animal model market is segmented into research & development, production & quality control, academics, preclinical applications and other applications. The research & development segment held majority market share in 2022 and is expected to witness notable growth to reach USD 22.1 billion by 2032. The increasing number of research & development projects and rise in the investments to develop novel therapeutics is set to drive the segment share. Animal models are used to feature some of the earliest developments related with the disease and to detect potential drug targets.
Further, the pharmacokinetic and pharmacodynamic experiments are conducted for evaluating gastrointestinal absorption, distribution, metabolism, and drug excretion (ADME) parameters for every drug candidate. Animal models are extensively employed in these ADME studies that aid in screening these drug candidates to move forward to the next step in safety and efficacy studies.
Based on use, the animal model market is segmented into human and veterinary. The human segment accounted for largest revenue share in 2022 and is anticipated to grow at significant 7.0% growth rate during the analysis period. This significant segmental revenue is majorly attributed to the increasing prevalence of chronic disorders such as cancer in humans and increasing demand for personalized medicine. According to the World Health Organization (WHO), in 2020, cancer is amongst the critical conditions inflicting substantial disease burden, accounting for approximately 10 million deaths.
Similarly, as per the Cancer Statistics, in 2020, around 1.8 million new cancer cases were diagnosed in the U.S. alone. Therefore, the rise in the prevalence of such chronic human ailments is set to foster the demand for novel therapeutics and effective drugs. This demand in turn is expected to push the use of animal models in drug research & development, thereby propelling the segment outlook.
Based on end-use, the animal model market is segmented into companies, organizations, academic & research institutes and CRO’s. Companies segment accounted for highest segment share in 2022. Heavy investment in research and development by pharmaceutical & biotechnology companies and the surged usage of animal models in these activities is expected to fuel the segment expansion. According to a report by Johnson & Johnson, in 2019, the R&D spending surged by 5% and the major 11 pharma companies accounted for a total of USD 77.6 billion. Thus, animal models are regarded as an essential tool to aid in making the decision to develop potential therapies from preclinical studies to human trials. The rise in the investment and increased demand for effective therapeutics is set to drive the acceptance of animal models.
North America animal model market is projected to expand at 7.1% growth rate over the analysis timeframe. This is due to increasing investments and high number of clinical trials conducted in the region. The region is marked by the presence of major players operating in the mice model market which positively influences the market growth. Further, growing biomedical research in the U.S., and rising preclinical activities by contract research organizations (CROs) and pharmaceutical companies in the region will accelerate the market share. Thus, the rising number of clinical trials and significant investments into these studies is expected to boost the regional market size.
Animal Model Market Share
Major market players operating in the animal model market include:
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Animal Model Industry News:
The animal model market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Animal Type
By Technology
By Application
By Use
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →